Articles published by NeurAxis, Inc.![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
NeurAxis Receives New FDA 510(K) Clearance for IB-Stim, Expanding its Addressable Market
November 04, 2024
From NeurAxis, Inc.
Via GlobeNewswire
![]() ![]() ![]() ![]() ![]() ![]()
NeurAxis Reports Second Quarter 2024 Financial Results
August 09, 2024
From NeurAxis, Inc.
Via GlobeNewswire
![]() ![]() ![]() From NeurAxis, Inc.
Via GlobeNewswire
![]() ![]() ![]() ![]() From NeurAxis, Inc.
Via GlobeNewswire
![]() From NeurAxis, Inc.
Via GlobeNewswire
![]() ![]() ![]()
NeurAxis Announces Highmark BCBS Policy Coverage
March 11, 2024
From NeurAxis, Inc.
Via GlobeNewswire
![]() From NeurAxis, Inc.
Via GlobeNewswire
![]()
NeurAxis to Present at Oppenheimer 34th Annual Healthcare MedTech & Services Conference
February 27, 2024
From NeurAxis, Inc.
Via GlobeNewswire
![]()
NeurAxis Appoints Timothy Henrichs as Chief Financial Officer
January 31, 2024
From NeurAxis, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|